Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: Effect on conventional coagulation tests and thrombomodulin-modified thrombin generation

Carregando...
Imagem de Miniatura
Citações na Scopus
65
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Citação
JOURNAL OF HEPATOLOGY, v.72, n.1, p.85-94, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background & Aims: The efficacy of fresh frozen plasma (FFP) transfusion in enhancing thrombin generation in patients with cirrhosis and impaired conventional coagulation tests has not been sufficiently explored. Thus, we aimed to assess the effect of FFP transfusion on thrombin generation in these patients. Methods: Fifty-three consecutive patients receiving a standard dose of FFP to treat bleeding and/or before invasive procedures - if international normalized ratio (INR)/prothrombin time (PT) ratio were >= 1.5 - were prospectively enrolled. The primary endpoint was the amelioration of endogenous thrombin potential (ETP) with thrombomodulin (ETP-TM) after transfusion, which corresponds to the total amount of generated thrombin. INR/PT ratio and activated partial thromboplastin time (aPTT) were also assessed before and after transfusion. Results: FFP enhanced ETP-TM by 5.7%, from 973 (731-1,258) to 1,028 (885-1,343 nM x min; p = 0.019). Before transfusion, evidence of normal or high ETP-TM was found in 94% of patients, even in those with bacterial infections. Only 1 (1.9%) patient had ETP-TM values reverting to the normal range after transfusion. Notably, no patients with low ETP-TM had bleeding. The median decrease in ETP-TM was 8.3% and the mean was 12.8% in 18 (34%) patients after transfusion (from 1,225 [1,071-1,537] to 1,124 [812-1,370] nM x min; p <= 0.0001). Similar responses to FFP transfusion were observed in patients with compensated and acute decompensated cirrhosis, acute-on-chronic liver failure, infection or shock. FFP significantly ameliorated INR and aPTT values (p <0.0001), but in a minority of patients the values were reduced to less than the cut-off point of 1.5. Conclusions: FFP transfusion enhanced thrombin generation and ameliorated conventional coagulation tests to normal values in a limited number of patients, and slightly decreased thrombin generation in 34% of cases. Lay summary: Transfusion of fresh frozen plasma in patients with cirrhosis only slightly improves coagulation test values in a limited number of patients and even appears to worsen them in a third of cases. Transfusion for the purpose of preventing or treating bleeding events could cause inherent risks and costs without clear benefits. (C) 2019 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
Palavras-chave
Cirrhosis, Thrombin generation, Fresh frozen plasma, Coagulation
Referências
  1. Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198
  2. Caldwell Stephen, 2012, Hepatology, V55, P1634, DOI 10.1002/hep.25623
  3. Carlier L, 2015, THROMB RES, V135, P192, DOI 10.1016/j.thromres.2014.11.001
  4. Castoldi E, 2011, THROMB RES, V127, pS21, DOI 10.1016/S0049-3848(11)70007-X
  5. Chandler JB, 2019, J CLIN PATHOL, V72, P177, DOI 10.1136/jclinpath-2018-205438
  6. da Saude do Brasil M, 2015, GUIA USO HEMOCOMPONE
  7. Desborough MJR, 2016, LIVER INT, V36, P522, DOI 10.1111/liv.12999
  8. Drolz A, 2016, HEPATOLOGY, V64, P556, DOI 10.1002/hep.28628
  9. Giannini EG, 2014, HEPATOLOGY, V60, P1442, DOI 10.1002/hep.27029
  10. Hall DP, 2012, BRIT J ANAESTH, V109, P919, DOI 10.1093/bja/aes337
  11. Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636
  12. HEMKER HC, 1986, THROMB HAEMOSTASIS, V56, P9
  13. Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK
  14. Hyytiainen S, 2003, J THROMB HAEMOST, V1, P1189, DOI 10.1046/j.1538-7836.2003.00243.x
  15. Lisman T, 2001, GASTROENTEROLOGY, V121, P131, DOI 10.1053/gast.2001.25481
  16. Lisman T, 2018, LIVER INT, V38, P1988, DOI 10.1111/liv.13882
  17. Liumbruno GM, 2011, BLOOD TRANSFUS-ITALY, V9, P320, DOI 10.2450/2011.0076-10
  18. Malloy PC, 2009, J VASC INTERV RADIOL, V20, pS240, DOI 10.1016/j.jvir.2008.11.027
  19. Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70
  20. Mannucci PM, 2006, J THROMB HAEMOST, V4, P721, DOI 10.1111/j.1538-7836.2006.01886.x
  21. Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449
  22. Montalto P, 2002, J HEPATOL, V37, P463, DOI 10.1016/S0168-8278(02)00208-8
  23. Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042
  24. Muller MCA, 2015, J THROMB HAEMOST, V13, P989, DOI 10.1111/jth.12908
  25. National Institute of Health, FRESH FROZ PLASM INF
  26. Qi XS, 2015, INTERN EMERG MED, V10, P205, DOI 10.1007/s11739-014-1163-7
  27. Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742
  28. Schols SEM, 2008, THROMB HAEMOSTASIS, V99, P64, DOI 10.1160/TH07-07-0438
  29. Shah NL, 2012, ANN HEPATOL, V11, P686, DOI 10.1016/S1665-2681(19)31443-7
  30. Szczepiorkowski ZM, 2013, HEMATOL-AM SOC HEMAT, P638, DOI 10.1182/asheducation-2013.1.638
  31. Tinmouth A, 2013, TRANSFUSION, V53, P2222, DOI 10.1111/trf.12231
  32. Tripodi A, 2005, HEPATOLOGY, V41, P553, DOI 10.1002/hep.20569
  33. Tripodi A, 2006, HEPATOLOGY, V44, P440, DOI 10.1002/hep.21266
  34. Tripodi A, 2016, DIGEST LIVER DIS, V48, P1208, DOI 10.1016/j.dld.2016.06.027
  35. Tripodi A, 2012, INTERN EMERG MED, V7, P139, DOI 10.1007/s11739-011-0528-4
  36. Tripodi A, 2009, GASTROENTEROLOGY, V137, P2105, DOI 10.1053/j.gastro.2009.08.045
  37. von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X
  38. Wu H, 2010, CLIN GASTROENTEROL H, V8, P800, DOI 10.1016/j.cgh.2010.05.014
  39. Yates SG, 2016, TRANSFUSION, V56, P791, DOI 10.1111/trf.13495
  40. Youngwon N, 2013, BIOMED RES INT, V2013, P1
  41. Youssef WI, 2003, AM J GASTROENTEROL, V98, P1391, DOI 10.1016/S0002-9270(03)00241-7
  42. ZIMMON DS, 1974, GUT, V15, P99, DOI 10.1136/gut.15.2.99